GO:0005488 | binding | 61.14% (140/229) | 0.95 | 0.0 | 0.0 |
GO:0003676 | nucleic acid binding | 28.82% (66/229) | 1.67 | 0.0 | 0.0 |
GO:0097159 | organic cyclic compound binding | 37.99% (87/229) | 1.0 | 0.0 | 0.0 |
GO:0005515 | protein binding | 27.07% (62/229) | 1.27 | 0.0 | 0.0 |
GO:0016070 | RNA metabolic process | 11.79% (27/229) | 2.2 | 0.0 | 0.0 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 10.92% (25/229) | 2.2 | 0.0 | 0.0 |
GO:0006396 | RNA processing | 7.42% (17/229) | 2.64 | 0.0 | 0.0 |
GO:0003724 | RNA helicase activity | 3.49% (8/229) | 4.41 | 0.0 | 0.0 |
GO:0008186 | ATP-dependent activity, acting on RNA | 3.49% (8/229) | 4.41 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 13.97% (32/229) | 1.67 | 0.0 | 0.0 |
GO:0003723 | RNA binding | 10.04% (23/229) | 1.96 | 0.0 | 2e-06 |
GO:0140513 | nuclear protein-containing complex | 6.11% (14/229) | 2.71 | 0.0 | 2e-06 |
GO:0008270 | zinc ion binding | 7.42% (17/229) | 2.26 | 0.0 | 6e-06 |
GO:0003674 | molecular_function | 69.0% (158/229) | 0.4 | 0.0 | 6e-06 |
GO:0006139 | nucleobase-containing compound metabolic process | 14.41% (33/229) | 1.41 | 0.0 | 1.1e-05 |
GO:0016071 | mRNA metabolic process | 4.37% (10/229) | 3.04 | 0.0 | 1.6e-05 |
GO:0006397 | mRNA processing | 3.93% (9/229) | 3.17 | 1e-06 | 2.6e-05 |
GO:0017056 | structural constituent of nuclear pore | 2.18% (5/229) | 4.75 | 1e-06 | 3.4e-05 |
GO:0004386 | helicase activity | 5.68% (13/229) | 2.42 | 1e-06 | 3.5e-05 |
GO:0140098 | catalytic activity, acting on RNA | 5.68% (13/229) | 2.41 | 1e-06 | 3.7e-05 |
GO:0046483 | heterocycle metabolic process | 14.41% (33/229) | 1.29 | 2e-06 | 5e-05 |
GO:0006725 | cellular aromatic compound metabolic process | 14.41% (33/229) | 1.28 | 2e-06 | 5.7e-05 |
GO:0043167 | ion binding | 25.33% (58/229) | 0.88 | 2e-06 | 5.9e-05 |
GO:1901360 | organic cyclic compound metabolic process | 14.41% (33/229) | 1.25 | 4e-06 | 8.2e-05 |
GO:0006913 | nucleocytoplasmic transport | 2.62% (6/229) | 3.83 | 4e-06 | 9.5e-05 |
GO:0140657 | ATP-dependent activity | 7.86% (18/229) | 1.81 | 5e-06 | 0.0001 |
GO:0051169 | nuclear transport | 2.62% (6/229) | 3.79 | 5e-06 | 0.000103 |
GO:0005634 | nucleus | 6.11% (14/229) | 2.0 | 1.4e-05 | 0.000269 |
GO:0000398 | mRNA splicing, via spliceosome | 2.62% (6/229) | 3.43 | 2.1e-05 | 0.0004 |
GO:0018024 | obsolete histone lysine N-methyltransferase activity | 1.75% (4/229) | 4.52 | 2.7e-05 | 0.000486 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 2.62% (6/229) | 3.3 | 3.5e-05 | 0.000623 |
GO:0035639 | purine ribonucleoside triphosphate binding | 15.72% (36/229) | 1.02 | 3.9e-05 | 0.000665 |
GO:0000375 | RNA splicing, via transesterification reactions | 2.62% (6/229) | 3.23 | 4.6e-05 | 0.00076 |
GO:0005524 | ATP binding | 14.41% (33/229) | 1.05 | 5.6e-05 | 0.000893 |
GO:0005643 | nuclear pore | 1.75% (4/229) | 4.22 | 6.3e-05 | 0.000972 |
GO:0032774 | RNA biosynthetic process | 3.93% (9/229) | 2.38 | 6.7e-05 | 0.001017 |
GO:0032555 | purine ribonucleotide binding | 15.72% (36/229) | 0.96 | 9.5e-05 | 0.001395 |
GO:0008380 | RNA splicing | 2.62% (6/229) | 3.03 | 0.000103 | 0.001468 |
GO:0032553 | ribonucleotide binding | 15.72% (36/229) | 0.94 | 0.000115 | 0.001604 |
GO:0034641 | cellular nitrogen compound metabolic process | 14.41% (33/229) | 0.99 | 0.000131 | 0.001733 |
GO:0097367 | carbohydrate derivative binding | 15.72% (36/229) | 0.93 | 0.000135 | 0.001745 |
GO:0017076 | purine nucleotide binding | 16.16% (37/229) | 0.92 | 0.000129 | 0.001755 |
GO:0032559 | adenyl ribonucleotide binding | 14.41% (33/229) | 0.98 | 0.000139 | 0.001762 |
GO:0043170 | macromolecule metabolic process | 23.14% (53/229) | 0.71 | 0.000167 | 0.002063 |
GO:0140658 | ATP-dependent chromatin remodeler activity | 1.75% (4/229) | 3.85 | 0.000175 | 0.002073 |
GO:0006405 | RNA export from nucleus | 1.31% (3/229) | 4.77 | 0.000174 | 0.002104 |
GO:0030554 | adenyl nucleotide binding | 14.85% (34/229) | 0.94 | 0.000186 | 0.002151 |
GO:0050658 | RNA transport | 1.31% (3/229) | 4.69 | 0.000204 | 0.002218 |
GO:0051236 | establishment of RNA localization | 1.31% (3/229) | 4.69 | 0.000204 | 0.002218 |
GO:0050657 | nucleic acid transport | 1.31% (3/229) | 4.69 | 0.000204 | 0.002218 |
GO:0043227 | membrane-bounded organelle | 6.11% (14/229) | 1.61 | 0.000245 | 0.002559 |
GO:0043231 | intracellular membrane-bounded organelle | 6.11% (14/229) | 1.61 | 0.000245 | 0.002559 |
GO:0031047 | regulatory ncRNA-mediated gene silencing | 1.31% (3/229) | 4.49 | 0.000313 | 0.003209 |
GO:0051168 | nuclear export | 1.31% (3/229) | 4.43 | 0.000356 | 0.003456 |
GO:0000166 | nucleotide binding | 16.16% (37/229) | 0.84 | 0.000354 | 0.003502 |
GO:1901265 | nucleoside phosphate binding | 16.16% (37/229) | 0.84 | 0.000354 | 0.003502 |
GO:0006357 | regulation of transcription by RNA polymerase II | 2.62% (6/229) | 2.68 | 0.000383 | 0.003659 |
GO:0005665 | RNA polymerase II, core complex | 0.87% (2/229) | 5.85 | 0.000494 | 0.004637 |
GO:0007062 | sister chromatid cohesion | 1.31% (3/229) | 4.26 | 0.000508 | 0.00468 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4.37% (10/229) | 1.83 | 0.000576 | 0.005135 |
GO:0046914 | transition metal ion binding | 7.42% (17/229) | 1.31 | 0.000575 | 0.00521 |
GO:0004722 | protein serine/threonine phosphatase activity | 1.75% (4/229) | 3.39 | 0.000599 | 0.005252 |
GO:0070063 | RNA polymerase binding | 0.87% (2/229) | 5.62 | 0.000689 | 0.005954 |
GO:1901363 | heterocyclic compound binding | 16.16% (37/229) | 0.78 | 0.000796 | 0.006764 |
GO:0043168 | anion binding | 15.72% (36/229) | 0.79 | 0.000826 | 0.006917 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 1.75% (4/229) | 3.24 | 0.000876 | 0.007219 |
GO:0036094 | small molecule binding | 16.16% (37/229) | 0.77 | 0.00094 | 0.007517 |
GO:0022402 | cell cycle process | 2.18% (5/229) | 2.75 | 0.00093 | 0.007554 |
GO:0043687 | post-translational protein modification | 3.49% (8/229) | 1.99 | 0.001033 | 0.008144 |
GO:0016570 | histone modification | 1.75% (4/229) | 3.16 | 0.001069 | 0.008311 |
GO:0006351 | DNA-templated transcription | 2.62% (6/229) | 2.39 | 0.001095 | 0.008387 |
GO:0005852 | eukaryotic translation initiation factor 3 complex | 1.31% (3/229) | 3.85 | 0.001192 | 0.009009 |
GO:0034062 | 5'-3' RNA polymerase activity | 1.75% (4/229) | 3.04 | 0.001477 | 0.010716 |
GO:0097747 | RNA polymerase activity | 1.75% (4/229) | 3.04 | 0.001477 | 0.010716 |
GO:0045292 | mRNA cis splicing, via spliceosome | 0.87% (2/229) | 5.11 | 0.001461 | 0.010884 |
GO:0065007 | biological regulation | 12.66% (29/229) | 0.85 | 0.001524 | 0.010908 |
GO:0006807 | nitrogen compound metabolic process | 23.58% (54/229) | 0.56 | 0.001785 | 0.012139 |
GO:0045930 | negative regulation of mitotic cell cycle | 0.87% (2/229) | 4.97 | 0.001778 | 0.012246 |
GO:0007093 | mitotic cell cycle checkpoint signaling | 0.87% (2/229) | 4.97 | 0.001778 | 0.012246 |
GO:0006304 | DNA modification | 0.87% (2/229) | 4.97 | 0.001778 | 0.012246 |
GO:0040029 | epigenetic regulation of gene expression | 1.31% (3/229) | 3.59 | 0.002 | 0.013435 |
GO:0051028 | mRNA transport | 0.87% (2/229) | 4.85 | 0.002126 | 0.013768 |
GO:0006406 | mRNA export from nucleus | 0.87% (2/229) | 4.85 | 0.002126 | 0.013768 |
GO:0032991 | protein-containing complex | 8.73% (20/229) | 1.03 | 0.002094 | 0.013893 |
GO:0031048 | regulatory ncRNA-mediated heterochromatin formation | 0.87% (2/229) | 4.73 | 0.002503 | 0.015128 |
GO:0006346 | DNA methylation-dependent heterochromatin formation | 0.87% (2/229) | 4.73 | 0.002503 | 0.015128 |
GO:0080188 | gene silencing by RNA-directed DNA methylation | 0.87% (2/229) | 4.73 | 0.002503 | 0.015128 |
GO:0097525 | spliceosomal snRNP complex | 0.87% (2/229) | 4.73 | 0.002503 | 0.015128 |
GO:0140718 | facultative heterochromatin formation | 0.87% (2/229) | 4.73 | 0.002503 | 0.015128 |
GO:0031323 | regulation of cellular metabolic process | 9.61% (22/229) | 0.95 | 0.002592 | 0.015493 |
GO:0048523 | negative regulation of cellular process | 2.62% (6/229) | 2.15 | 0.002489 | 0.015932 |
GO:0101005 | deubiquitinase activity | 1.75% (4/229) | 2.8 | 0.002694 | 0.015932 |
GO:0019783 | ubiquitin-like protein peptidase activity | 1.75% (4/229) | 2.79 | 0.002794 | 0.016344 |
GO:0031326 | regulation of cellular biosynthetic process | 9.17% (21/229) | 0.94 | 0.003424 | 0.01757 |
GO:0009889 | regulation of biosynthetic process | 9.17% (21/229) | 0.94 | 0.003424 | 0.01757 |
GO:0048519 | negative regulation of biological process | 2.62% (6/229) | 2.06 | 0.003384 | 0.017702 |
GO:0004721 | phosphoprotein phosphatase activity | 1.75% (4/229) | 2.74 | 0.003108 | 0.017799 |
GO:0000075 | cell cycle checkpoint signaling | 0.87% (2/229) | 4.52 | 0.003344 | 0.017832 |
GO:0007064 | mitotic sister chromatid cohesion | 0.87% (2/229) | 4.52 | 0.003344 | 0.017832 |
GO:0010948 | negative regulation of cell cycle process | 0.87% (2/229) | 4.52 | 0.003344 | 0.017832 |
GO:0030532 | small nuclear ribonucleoprotein complex | 0.87% (2/229) | 4.52 | 0.003344 | 0.017832 |
GO:1901988 | negative regulation of cell cycle phase transition | 0.87% (2/229) | 4.52 | 0.003344 | 0.017832 |
GO:0010556 | regulation of macromolecule biosynthetic process | 9.17% (21/229) | 0.94 | 0.003382 | 0.017864 |
GO:0019222 | regulation of metabolic process | 9.61% (22/229) | 0.93 | 0.003107 | 0.017982 |
GO:0018130 | heterocycle biosynthetic process | 4.37% (10/229) | 1.48 | 0.003556 | 0.018082 |
GO:0043412 | macromolecule modification | 10.92% (25/229) | 0.84 | 0.003649 | 0.018382 |
GO:0010468 | regulation of gene expression | 9.17% (21/229) | 0.94 | 0.003301 | 0.018511 |
GO:0019438 | aromatic compound biosynthetic process | 4.37% (10/229) | 1.49 | 0.003284 | 0.01861 |
GO:0015931 | nucleobase-containing compound transport | 1.31% (3/229) | 3.26 | 0.003837 | 0.018638 |
GO:0005694 | chromosome | 0.87% (2/229) | 4.43 | 0.003807 | 0.018656 |
GO:0032784 | regulation of DNA-templated transcription elongation | 0.87% (2/229) | 4.43 | 0.003807 | 0.018656 |
GO:0120114 | Sm-like protein family complex | 0.87% (2/229) | 4.43 | 0.003807 | 0.018656 |
GO:0010629 | negative regulation of gene expression | 1.75% (4/229) | 2.65 | 0.003933 | 0.018935 |
GO:0050789 | regulation of biological process | 11.79% (27/229) | 0.79 | 0.004113 | 0.019628 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 0.87% (2/229) | 4.34 | 0.004298 | 0.02033 |
GO:0043169 | cation binding | 9.61% (22/229) | 0.87 | 0.004866 | 0.02282 |
GO:0043229 | intracellular organelle | 7.42% (17/229) | 1.01 | 0.005318 | 0.024518 |
GO:0043226 | organelle | 7.42% (17/229) | 1.01 | 0.005318 | 0.024518 |
GO:0036211 | protein modification process | 10.04% (23/229) | 0.83 | 0.005364 | 0.024522 |
GO:1900150 | regulation of defense response to fungus | 0.87% (2/229) | 4.11 | 0.005936 | 0.025628 |
GO:0000428 | DNA-directed RNA polymerase complex | 0.87% (2/229) | 4.11 | 0.005936 | 0.025628 |
GO:0005682 | U5 snRNP | 0.44% (1/229) | 7.43 | 0.005798 | 0.025642 |
GO:0004712 | protein serine/threonine/tyrosine kinase activity | 0.44% (1/229) | 7.43 | 0.005798 | 0.025642 |
GO:0051304 | chromosome separation | 0.44% (1/229) | 7.43 | 0.005798 | 0.025642 |
GO:0060255 | regulation of macromolecule metabolic process | 9.17% (21/229) | 0.87 | 0.005717 | 0.025916 |
GO:0016579 | protein deubiquitination | 1.31% (3/229) | 3.04 | 0.005914 | 0.025943 |
GO:0007346 | regulation of mitotic cell cycle | 0.87% (2/229) | 4.04 | 0.006536 | 0.02735 |
GO:0046872 | metal ion binding | 9.17% (21/229) | 0.86 | 0.00642 | 0.027501 |
GO:0018193 | peptidyl-amino acid modification | 1.75% (4/229) | 2.44 | 0.006525 | 0.027518 |
GO:1901362 | organic cyclic compound biosynthetic process | 4.37% (10/229) | 1.35 | 0.006503 | 0.027639 |
GO:0030880 | RNA polymerase complex | 0.87% (2/229) | 3.97 | 0.007162 | 0.029076 |
GO:0070646 | protein modification by small protein removal | 1.31% (3/229) | 2.95 | 0.007014 | 0.029127 |
GO:0140097 | catalytic activity, acting on DNA | 3.49% (8/229) | 1.53 | 0.007095 | 0.029242 |
GO:0050794 | regulation of cellular process | 10.92% (25/229) | 0.76 | 0.007149 | 0.029243 |
GO:0045786 | negative regulation of cell cycle | 0.87% (2/229) | 3.91 | 0.007815 | 0.030805 |
GO:0034968 | histone lysine methylation | 0.87% (2/229) | 3.91 | 0.007815 | 0.030805 |
GO:0016571 | histone methylation | 0.87% (2/229) | 3.91 | 0.007815 | 0.030805 |
GO:0016779 | nucleotidyltransferase activity | 2.18% (5/229) | 2.04 | 0.007797 | 0.031421 |
GO:0032101 | regulation of response to external stimulus | 0.87% (2/229) | 3.79 | 0.009196 | 0.03548 |
GO:1901987 | regulation of cell cycle phase transition | 0.87% (2/229) | 3.79 | 0.009196 | 0.03548 |
GO:0002831 | regulation of response to biotic stimulus | 0.87% (2/229) | 3.79 | 0.009196 | 0.03548 |
GO:0031347 | regulation of defense response | 0.87% (2/229) | 3.73 | 0.009925 | 0.037755 |
GO:0004843 | cysteine-type deubiquitinase activity | 1.31% (3/229) | 2.77 | 0.00991 | 0.037963 |
GO:0046982 | protein heterodimerization activity | 1.75% (4/229) | 2.25 | 0.010295 | 0.038891 |
GO:0018022 | peptidyl-lysine methylation | 0.87% (2/229) | 3.68 | 0.010678 | 0.040061 |
GO:0031056 | regulation of histone modification | 0.44% (1/229) | 6.43 | 0.011562 | 0.041932 |
GO:1901983 | regulation of protein acetylation | 0.44% (1/229) | 6.43 | 0.011562 | 0.041932 |
GO:0071013 | catalytic step 2 spliceosome | 0.44% (1/229) | 6.43 | 0.011562 | 0.041932 |
GO:2000756 | regulation of peptidyl-lysine acetylation | 0.44% (1/229) | 6.43 | 0.011562 | 0.041932 |
GO:0035065 | regulation of histone acetylation | 0.44% (1/229) | 6.43 | 0.011562 | 0.041932 |
GO:0006470 | protein dephosphorylation | 1.31% (3/229) | 2.68 | 0.011776 | 0.042426 |
GO:1990234 | transferase complex | 2.18% (5/229) | 1.86 | 0.012677 | 0.04537 |